Hi All,

I am working on conjugating Anti-EGFR antibodies to the surface of PLGA-PEG-maleimide nanoparticles to target tumor cells over-expressing EGFR.

My question is approximately what ratio of mAB to nanoparticle should I aim for in order to achieve good targeting. Does anyone have experience here they would like to share?

All help is greatly appreciated!

EF

More Eduard Fidler's questions See All
Similar questions and discussions